Skip to content

A study in women with overweight or obesity to test whether different doses of BI 456906 influence the amount of a contraceptive in the blood

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2022-503146-53-00
Acronym
1404-0014
Enrollment
24
Registered
2023-08-16
Start date
2023-12-07
Completion date
2025-03-26
Last updated
2025-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pharmacokinetic trial

Interventions

None listed

Sponsors

Boehringer Ingelheim International GmbH
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026